ResearchMoz added Latest Research Report titled ” Personalized Medicine in Oncology Partnering Terms and Agreements ” to it’s Large Report database.
The Personalized Medicine in Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine in oncology partnering agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter personalized medicine in oncology partnering deals. The majority of deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=182391
The initial chapters of this report provide an orientation of personalized medicine in oncology dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst
Chapter 2 provides an overview of the trends in personalized medicine in oncology dealmaking since 2009, including details of average headline, upfront, milestone and royalty terms.It also provides the number of deals entered by top 50 big pharma and most active dealmakers in personalized medicine in oncology partnering.
Chapter 3 provides a review of the leading personalized medicine in oncology deals since 2009. Deals are listed by headline value signed by all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html
Table of Content
Chapter 1 – Introduction
Chapter 2 – Trends in personalized medicine in oncology dealmaking
2.2. Personalized medicine in oncology partnering over the years
2.2.1 Biomarkers in oncology partnering over the years
2.2.2 Companion diagnostic in oncology partnering over the years
2.2.3 Pharmacogenomics in oncology partnering over the years
2.3. Big pharma personalized medicine in oncology dealmaking activity
2.3.1 Big pharma biomarker, companion diagnostic and pharmacogenomics in oncology dealmaking activity
2.4. Most active in personalized medicine in oncology
2.5. Personalized medicine in oncology partnering by deal type
2.5.1 Biomarker partnering in oncology by deal type
2.5.2 Companion diagnostic in oncology partnering by deal type
2.5.3 Pharmacogenomics in oncology partnering by deal type
2.6. Personalized medicine partnering by oncology disease type
2.6.1 Biomarker partnering by oncology disease type
2.6.2 Companion diagnostic partnering by disease type
2.6.3 Pharmacogenomics partnering by oncology disease type
2.7. Personalized medicine in oncology partnering by stage of development
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Albany NY, United States – 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/